New hope for Hard-to-Treat cancers: PTT-4256 enters human trials
Disease control
Recruiting now
This early-stage trial tests a new drug called PTT-4256 in 30 adults with advanced solid tumors that have spread. The main goal is to check safety and find the best dose. Researchers will also look for early signs that the drug shrinks tumors or slows cancer growth.
Phase: PHASE1, PHASE2 • Sponsor: Pathios Therapeutics Pty Ltd • Aim: Disease control
Last updated May 17, 2026 01:50 UTC